Baytown Endoscopy Center LLC Pearland, TX - 77584

Baytown Endoscopy Center LLC is categorized under Copying and Duplicating Services in Pearland, TX and active since 2011.

Baytown Endoscopy Center LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Copying and Duplicating Services business, which does work in the B2B market, and is classified as a Copying and Duplicating Services, under code number 323111 by the NAICS.

If you are seeking more information, feel free to contact Nilofar Jiwani at the company’s single location by writing to 2806 Sable Drive, Pearland, Texas TX 77584 or by phoning (713) 436-5654. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Baytown Endoscopy Center LLC
Contact Person: Nilofar Jiwani
Address: 2806 Sable Drive, Pearland, Texas 77584
Phone Number: (713) 436-5654
Annual Revenue (USD): $100.000 to $499.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Copying and Duplicating Services
SIC Code: 7334
NAICS Code: 323111
Share This Business:

Baytown Endoscopy Center LLC was started in 2011 to provide professional Copying and Duplicating Services under the SIC code 7334 and NAICS code 323111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Nilofar Jiwani for inquiries that concern Baytown Endoscopy Center LLC by calling the company number (713) 436-5654, as your correspondence is most welcome. Additionally, the physical location of the single location of Baytown Endoscopy Center LLC can be found at the coordinates 29.54546,-95.377669 as well as the street address 2806 Sable Drive in Pearland, Texas 77584.

For its online presence, you may visit Baytown Endoscopy Center LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.